{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/BCRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T06:06:28.155Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9556,"canonical_name":"BIOCRYST PHARMACEUTICALS INC","cik":"0000882796","uei":null,"lei":null,"duns":null,"ticker":"BCRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":27},"count":27,"timeline":[{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — BIOCRYST PHARMACEUTICALS INC — 2026-08-07","url_slug":"/sec/cik-0000882796/schedule-13g/0000093751-26-000420","accession_number":"0000093751-26-000420","importance":55},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — BIOCRYST PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0000882796/10-q/0001628280-26-053300","accession_number":"0001628280-26-053300","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — BIOCRYST PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0000882796/8-k/0001171843-26-005223","accession_number":"0001171843-26-005223","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"S-8","title":"S-8 — BIOCRYST PHARMACEUTICALS INC — 2026-08-05","url_slug":"/sec/cik-0000882796/s-8/0001171843-26-005245","accession_number":"0001171843-26-005245","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — BIOCRYST PHARMACEUTICALS INC — 2026-08-04","url_slug":"/sec/cik-0000882796/8-k-a/0001171843-26-005168","accession_number":"0001171843-26-005168","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — BIOCRYST PHARMACEUTICALS INC — 2026-06-29","url_slug":"/sec/cik-0000882796/8-k/0001171843-26-004333","accession_number":"0001171843-26-004333","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — BIOCRYST PHARMACEUTICALS INC — 2026-06-12","url_slug":"/sec/cik-0000882796/8-k/0001171843-26-004096","accession_number":"0001171843-26-004096","importance":35},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"LEVIN ALAN G","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"MILANO VINCENT","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Stonehouse Jon P","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Galson Steven K","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Frank Steven","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"Milne Jill C.","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"SANDERS MACHELLE","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"HEGGIE THERESA","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-11","kind":"sec.insider.a","reporter":"McKee Amy E","title":null,"shares":15294,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Milne Jill C. — 2026-06-02","url_slug":"/sec/cik-0001644246/4/0000882796-26-000033","accession_number":"0000882796-26-000033","importance":30},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Frank Steven","title":null,"shares":1262,"price_per_share":8.91,"usd_value":11244,"security_title":"Common Stock","importance":15.01124442},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Milne Jill C.","title":null,"shares":1262,"price_per_share":8.91,"usd_value":11244,"security_title":"Common Stock","importance":15.01124442},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"MILANO VINCENT","title":null,"shares":1122,"price_per_share":8.91,"usd_value":9997,"security_title":"Common Stock","importance":15.00999702},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"Stonehouse Jon P","title":null,"shares":631,"price_per_share":8.91,"usd_value":5622,"security_title":"Common Stock","importance":15.00562221},{"ts":"2026-05-29","kind":"sec.insider.a","reporter":"McKee Amy E","title":null,"shares":631,"price_per_share":8.91,"usd_value":5622,"security_title":"Common Stock","importance":15.00562221},{"ts":"2026-05-18","kind":"sec.form144","reporter":"Amy McKee","title":"Director","shares":11180,"usd_value":99906,"security_title":"Common","approx_sale_date":"2026-05-18","accession_number":"0001628280-26-036012","importance":40.0199812},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"McKee Amy E","title":null,"shares":11180,"price_per_share":8.97,"usd_value":100285,"security_title":"Common Stock","importance":35.1002846},{"ts":"2026-05-13","kind":"sec.form144","reporter":"Barnes Alane P","title":"Officer","shares":62500,"usd_value":596250,"security_title":"Common","approx_sale_date":"2026-05-13","accession_number":"0001959173-26-003553","importance":40.11925},{"ts":"2026-05-13","kind":"sec.insider.s","reporter":"Barnes Alane P","title":"Chief Legal Officer","shares":62500,"price_per_share":9.54,"usd_value":596250,"security_title":"Common Stock","importance":35.59625},{"ts":"2026-05-13","kind":"sec.insider.m","reporter":"Barnes Alane P","title":"Chief Legal Officer","shares":62500,"price_per_share":5.04,"usd_value":315000,"security_title":"Common Stock","importance":15.315}]}